Skip to main content
. 2024 Mar 8;6(10):181–188. doi: 10.46234/ccdcw2024.037

Table 1. Baseline characteristics of 5,169,812 reproductive-aged women in China, 2013–2017.

Maternal characteristic Total (n=5,169,812) ALT level (U/L) P value*
<20 (n=3,223,504) 20–40 (n=1,681,607) >40 (n=264,701)
Abbreviation: ALT=alanine aminotransferase; IQR=interquartile range; SD=standard deviation; LMP=last menstrual period; BMI=body mass index; HBsAg=hepatitis B surface antigen.
* Multiple comparison with Bonferroni-adjusted P<0.05 compared with the ALT 20–40 U/L group (<20 U/L group vs. 20–40 U/L group; >40 U/L group vs. 20–40 U/L group).
† The Kruskal-Wallis H test was used to examine the differences of baseline characteristics among ALT groups; otherwise, the χ2 test was used.
Age at LMP (years), mean (SD) 26.52 (4.21) 26.52 (4.16) 26.52 (4.30) 26.46 (4.27) <0.001†
Age at LMP (years), n (%) <0.001†
20–24 1,811,519 (35.04) 1,112,313 (34.51) 601,897 (35.79) 97,309 (36.76)
25–29 2,327,309 (45.02) 1,477,004 (45.82) 736,831 (43.82) 113,474 (42.87)
30–34 741,964 (14.35) 459,234 (14.25) 243,827 (14.50) 38,903 (14.70)
35–39 241,702 (4.68) 147,047 (4.56) 81,958 (4.87) 12,697 (4.80)
≥40 47,318 (0.92) 27,906 (0.87) 17,094 (1.02) 2,318 (0.88)
Preconception BMI (kg/m2), n (%) <0.001†
<18.5 698,452 (13.51) 481,090 (14.92) 189,707 (11.28) 27,655 (10.45)
18.5–23.9 3,665,734 (70.91) 2,295,998 (71.23) 1,196,830 (71.17) 172,906 (65.32)
24.0–27.9 635,294 (12.29) 356,654 (11.06) 232,028 (13.80) 46,612 (17.61)
≥28 145,745 (2.82) 71,746 (2.23) 57,561 (3.42) 16,438 (6.21)
Missing 24,587 (0.48) 18,016 (0.56) 5,481 (0.33) 1,090 (0.41)
Education, n (%) <0.001
Junior high school and below 3,135,739 (60.65) 1,892,092 (58.70) 1,079,663 (64.20) 163,984 (61.95)
Senior high school or above 1,879,334 (36.35) 1,226,039 (38.03) 561,238 (33.38) 92,057 (34.78)
Missing 154,739 (2.99) 105,373 (3.27) 40,706 (2.42) 8,660 (3.27)
Nationality, n (%) <0.001
Han 4,754,322 (91.96) 2,973,137 (92.23) 1,541,688 (91.68) 239,497 (90.48)
Other 354,381 (6.85) 208,609 (6.47) 124,208 (7.39) 21,564 (8.15)
Missing 61,109 (1.18) 41,758 (1.30) 15,711 (0.93) 3,640 (1.38)
Occupation, n (%) <0.001
Farmer 3,670,941 (71.01) 2,215,353 (68.72) 1,268,826 (75.45) 186,762 (70.56)
Non-farmer 1,329,778 (25.72) 893,104 (27.71) 368,175 (21.89) 68,499 (25.88)
Missing 169,093 (3.27) 115,047 (3.57) 44,606 (2.65) 9,440 (3.57)
Residence, n (%) <0.001
Rural 4,719,410 (91.29) 2,915,213 (90.44) 1,561,686 (92.87) 242,511 (91.62)
Urban 449,991 (8.70) 307,948 (9.55) 119,867 (7.13) 22,176 (8.38)
Missing 411 (0.01) 343 (0.01) 54 (0.00) 14 (0.01)
Region, n (%) <0.001
Eastern 1,800,946 (34.84) 1,539,760 (47.77) 889,719 (52.91) 89,548 (33.83)
Central 2,552,013 (49.36) 1,236,843 (38.37) 474,555 (28.22) 122,534 (46.29)
Western 816,853 (15.80) 446,901 (13.86) 317,333 (18.87) 52,619 (19.88)
Parity, n (%) <0.001
Primipara 3,158,062 (61.09) 1,960,188 (60.81) 1,030,173 (61.26) 167,701 (63.35)
Multipara 2,011,750 (38.91) 1,263,316 (39.19) 651,434 (38.74) 97,000 (36.65)
Hypertension, n (%) <0.001
No 5,055,184 (97.78) 3,154,849 (97.87) 1,644,195 (97.78) 256,140 (96.77)
Yes 81,071 (1.57) 47,032 (1.46) 27,382 (1.63) 6,657 (2.51)
Missing 33,557 (0.65) 21,623 (0.67) 10,030 (0.60) 1,904 (0.72)
Hyperglycemia, n (%) <0.001
No 4,937,590 (95.51) 3,079,691 (95.54) 1,612,949 (95.92) 244,950 (92.54)
Yes 201,358 (3.89) 123,428 (3.83) 59,698 (3.55) 18,232 (6.89)
Missing 30,864 (0.60) 20,385 (0.63) 8,960 (0.53) 1,519 (0.57)
Smoking, n (%) <0.001
No 5,132,139 (99.27) 3,198,243 (99.22) 1,671,189 (99.38) 262,707 (99.25)
Yes 10,608 (0.21) 6,761 (0.21) 3,156 (0.19) 691 (0.26)
Missing 27,065 (0.52) 18,500 (0.57) 7,262 (0.43) 1,303 (0.49)
Drinking, n (%) <0.001
No 4,997,403 (96.67) 3,104,545 (96.31) 1,636,845 (97.34) 256,013 (96.72)
Yes 140,600 (2.72) 97,448 (3.02) 36,014 (2.14) 7,138 (2.70)
Missing 31,809 (0.62) 21,511 (0.67) 8,748 (0.52) 1,550 (0.59)
Periconception folic acid intake, n (%) <0.001
No 1,059,359 (20.49) 650,583 (20.18) 354,576 (21.09) 54,200 (20.48)
Yes 4,055,168 (78.44) 2,536,091 (78.67) 1,311,328 (77.98) 207,749 (78.48)
Missing 55,285 (1.07) 36,830 (1.14) 15,703 (0.93) 2,752 (1.04)
Preconception harmful exposure, n (%) <0.001
No 4,555,857 (88.12) 2,815,462 (87.34) 1,508,161 (89.69) 232,234 (87.73)
Yes 586,854 (11.35) 389,622 (12.09) 166,073 (9.88) 31,159 (11.77)
Missing 27,101 (0.52) 18,420 (0.57) 7,373 (0.44) 1,308 (0.49)
History of adverse pregnancy outcomes, n (%) <0.001
No 4,337,030 (83.89) 2,684,307 (83.27) 1,436,552 (85.43) 216,171 (81.67)
Yes 832,782 (16.11) 539,197 (16.73) 245,055 (14.57) 48,530 (18.33)
Serum HBsAg status, n (%) <0.001
Negative 4,920,895 (95.19) 3,109,439 (96.46) 1,579,261 (93.91) 232,195 (87.72)
Positive 244,832 (4.74) 111,470 (3.46) 101,070 (6.01) 32,292 (12.20)
Missing 4,085 (0.08) 2,595 (0.08) 1,276 (0.08) 214 (0.08)